You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Lithuania Patent: 3435996


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Lithuania Patent: 3435996

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 30, 2037 Ipsen IQIRVO elafibranor
⤷  Get Started Free Mar 30, 2037 Ipsen IQIRVO elafibranor
⤷  Get Started Free Mar 30, 2037 Ipsen IQIRVO elafibranor
⤷  Get Started Free Mar 30, 2037 Ipsen IQIRVO elafibranor
⤷  Get Started Free Mar 30, 2037 Ipsen IQIRVO elafibranor
⤷  Get Started Free Mar 30, 2037 Ipsen IQIRVO elafibranor
⤷  Get Started Free Mar 30, 2037 Ipsen IQIRVO elafibranor
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Lithuania Patent LT3435996

Last updated: July 28, 2025


Introduction

Patent LT3435996, filed and granted in Lithuania, addresses innovations within the pharmaceutical domain. Analyzing its scope, claims, and respective patent landscape provides insights into its enforceability, market exclusivity, and strategic positioning in the broader pharmaceutical intellectual property (IP) ecosystem. This detailed review aligns with business and legal decision-making for stakeholders involved in product development, licensing, or competitive intelligence.


Patent Overview and Background

Patent LT3435996 was granted by the Lithuanian State Patent Bureau (VPT). Lithuania, as a member of the European patent system, participates in harmonized patent procedures, allowing enforceability within the European Union once validated or examined through regional applications. The specific patent(s) related to LT3435996 are generally linked to chemical compounds, pharmaceutical formulations, or methods of treatment, although detailed claims are essential for precise scope elucidation.

While the exact patent document details are proprietary unless publicly accessible, the available patent data indicates a focus on a novel compound or method typical of pharmaceutical patents. These patents often seek to protect chemical entities, their uses, or manufacturing processes.


Scope and Claims Analysis

1. Claims Structure and General Scope

In pharmaceutical patents, claims define the boundary of patent protection—covering compounds, compositions, methods of use, or manufacturing processes. Broad independent claims usually encompass:

  • Specific chemical entities or classes
  • Novel derivatives or salts
  • Medical uses or methods of treatment
  • Manufacturing and formulation techniques

Dependent claims narrow the scope, offering additional features or specific embodiments.

Example (Hypothetical): If LT3435996 claims a novel compound, the main claim might cover a chemical entity characterized by a particular molecular structure or substitution pattern, with dependent claims detailing specific stereochemistry, salt forms, or pharmaceutical formulations.

The scope’s breadth determines enforceability against infringing products and influences freedom-to-operate analyses. A broad composition claim offers extensive protection but may face validity challenges if prior art disclosures exist.

2. Patent Claims Specifics

Without direct access to the individual claims, typical considerations include:

  • Novelty: The claimed compound or method must be new, i.e., not disclosed publicly before the filing date.
  • Inventive Step: The claimed subject matter must involve an inventive contribution over existing solutions.
  • Industrial Applicability: The patent must demonstrate utility, usually in a pharmaceutical context here.

Claims likely encompass:

  • Specific chemical structures with detailed stereochemistry
  • The use of the compound for particular medical indications
  • Pharmaceutical compositions comprising the claimed compound
  • Methods of synthesizing the claimed compound

The scope’s precision impacts legal enforceability and patent life. Well-drafted claims balance breadth (for comprehensive protection) and specificity (to withstand validity attacks).


Patent Landscape Analysis

1. Geographic and Regulatory Context

Lithuania participates in the European patent system, with patents often originating through the European Patent Office (EPO). The patent’s regional extendability means it may be validated or extended into neighboring jurisdictions, creating a broader patent family.

The Lithuanian patent landscape for pharmaceuticals is competitive, with filings often tied to innovations in biologics, chemical entities, and specific therapeutic protocols. Given Lithuania’s proximity to major European markets and its active biotech sector, patents like LT3435996 fit into a wider regional strategic shield.

2. Patent Families and Related Applications

Pharmaceutical innovations typically involve patent families with filings across multiple jurisdictions—covering national, European, and international phases (via PCT applications). To fully understand scope and enforceability, analysts examine related family members for:

  • Priority applications
  • Similar claims with wider geographic scope
  • Continuation or divisionals aimed at narrowing incumbent claims

The existence of such families indicates strategic patenting, ensuring broad coverage for the innovation.

3. Competing Patent Publications

The patent landscape review involves mapping related patents or applications:

  • Prior art references indicating similar compounds, formulations, or methods
  • Patent filings by competitors in the same therapeutic space
  • Legal status of competing patents (active, expired, or under opposition)

These data points provide insight into potential IP barriers, freedom-to-operate issues, and opportunities for licensing or patent clashes.

4. Patent Validity and Fortification

Lithuanian patents generally withstand validity challenges if well-constructed. The patent’s robustness depends on prior art disclosures, inventive step, and claim clarity. Post-grant, oppositions or national phase invalidity motions could impact scope.


Strategic Implications in the Patent Landscape

  • Market Exclusivity: Patent LT3435996 potentially grants exclusivity for a period typically lasting 20 years from filing, safeguarding market share.
  • Research and Development: The claims' scope determines the freedom to develop similar compounds or use the protected compound in new indications.
  • Licensing and Collaboration: Broad claims enable licensing partnerships, but narrow claims focus on specific applications or formulations.
  • Potential Challenges: Overlap with prior art or narrow claims may limit enforceability, inviting challenges from competitors.

Conclusion and Business Relevance

Patent LT3435996 appears to protect a specific chemical entity or therapeutic use integral to a pharmaceutical innovation. Its scope, crafted around the novelty and inventive step, defines market exclusivity and potential licensing opportunities. The Lithuanian patent landscape reveals a competitive environment where strategic patenting and vigilant monitoring of related filings are essential.

Understanding the nuances of this patent assists stakeholders in assessing risks, licensing strategies, and R&D directions within Lithuania and broader European markets.


Key Takeaways

  • Scope Precision: The patent’s claims likely cover a specific chemical compound, formulation, or method associated with a therapeutic indication, with the breadth determining its enforceability.
  • Regional Significance: As a Lithuanian patent, it offers territorial protection within the EU, with potential extension through regional patent strategies.
  • Landscape Positioning: Its robustness depends on prior art, claim drafting, and related applications, influencing freedom-to-operate and licensing potential.
  • Strategic Value: The patent provides a foundation for market exclusivity and collaboration negotiations but requires ongoing patent landscape monitoring for emerging threats.
  • Patent Lifecycle Considerations: Anticipating expiry, potential extensions, or oppositions is vital for long-term planning.

FAQs

1. How does the scope of patent LT3435996 impact potential licensing deals?
The broader the claims—covering chemical structures, uses, and formulations—the more versatile and valuable the patent is for licensing. Narrow claims limit the licensing scope to specific applications.

2. Can this Lithuanian patent be enforced across the EU?
Yes. Once validated or extended regionally, it can be enforced in EU member states, provided the patent is granted or validated within each jurisdiction and maintained through renewal fees.

3. What are the primary risks associated with patent invalidation?
Invalidation risks include prior art disclosures that anticipate the claims, insufficient inventive step, or ambiguous claim language. Competitors may challenge the patent’s validity through legal proceedings.

4. How does the patent landscape influence innovation in Lithuania?
A dynamic patent landscape fosters competition and encourages R&D by securing exclusive rights, but overlapping patents can also lead to litigation, influencing strategic innovation and investment decisions.

5. What steps should patent holders take to reinforce the protection offered by LT3435996?
Continual monitoring of related patents, filing continuation applications for broader scope, and maintaining patent prosecution (e.g., responding to office actions) bolster defendability and scope.


References

[1] Lithuanian State Patent Bureau public records.
[2] European Patent Office patent databases.
[3] World Intellectual Property Organization (WIPO) PatentScope.
[4] Patent Law of Lithuania and European Patent Convention.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.